Friday, March 28, 2025

Day One
7:30-8:00 AM

Registration

8:00-8:15 AM

Welcome Remarks
Carl Salzman, MD; Matcheri Keshavan, MD

8:15-9:00 AM

Update on the Neurobiology for the Practicing Clinician: Understanding Brain Function and its Clinical Relevance
Matcheri Keshavan, MD

9:00-9:45 AM

Treatment-Resistant Depression: Update on New Antidepressants, Polypharmacy, Augmentation Strategies, Ketamine, Psychedelics, and ECT 
Alan Schatzberg, MD

9:45-10:30 AM

Treatment of Bipolar Disorders; Neurobiology and Clinical Directions; Revival of Lithium
Roscoe Brady, MD

10:30-10:45 AM

Coffee Break

10:45-11:30 AM

Update: The Psychopharmacology of the Reproductive Life Cycle: Premenstrual, Pregnancy, Lactation, and Menopause
Kristina Deligiannidis, MD

11:30 AM-12:15 PM

Psychopharmacologic Approaches in Childhood Affective Disorders
Melissa Delbello, MD, MS

12:15-12:45 PM

Panel Discussion #1
Roscoe Brady, MD; Matcheri Keshavan, MD; Alan Schatzberg, MD; Kristina Deligiannidis, MD; Melissa Delbello, MD, MS

12:45-1:45 PM

Lunch 

1:45-2:30 PM

Clinical Relevance of Brain Circuity for Psychiatric Treatment
Roscoe Brady, MD 

2:30-3:15 PM

Psychopharmacology in Geriatrics and Neuropsychiatry
Alejandro (Danny) Mendoza, MD

3:15-3:30 PM

Coffee Break

3:30-4:15 PM

Therapeutic Approaches to the Difficult Patient
Stephen Stahl, MD, PhD, DSc (Hon)

4:15-5:00 PM

Panel Discussion #2
Roscoe Brady, MD; Alejandro (Danny) Mendoza, MD; Stephen Stahl, MD, PhD, DSc (Hon)

Saturday, March 29, 2025

Day Two
8:30-9:15 AM

Treatment of Anxiety Spectrum Disorders, and PTSD, New Benzodiazepine Data
Carl Salzman, MD

9:15-10:15 AM

Neurobiology and Treatment of Sleep in Psychiatric Disorders
John Winkelman, MD; Tony Cunningham, PhD

10:15-10:30 AM

Coffee Break

10:30-11:15 AM

Update: Digital Phenotyping in Psychiatry and Psychopharmacology; Role of AI?
John Torous, MD, MBI

11:15 AM-12:00 PM

Clinical Use for Psychedelics? Use for PTSD?
Ryan Henner, MD

12:00-12:45 PM

Panel Discussion #1
Carl Salzman, MD; John Torous, MD, MBI; John Winkelman, MD; Ryan Henner, MD; Tony Cunningham, PhD

12:45-1:45 PM

Lunch 

1:45-2:30 PM

Update: Effective Treatment of Substance Use Disorders
Kevin Hill, MD

2:30-3:15 PM

Treatment for Schizophrenia: Prodrome First Episode, Relapse and New Treatment Possibilities
Matcheri Keshavan, MD

3:15-3:30 PM

Coffee Break

3:30-4:15 PM

Psychopharmacology of Trauma Related Disorders
Charles Nemeroff, MD, PhD

4:15-4:45 PM

Panel Discussion #2
Carl Salzman, MD; Charles Nemeroff, MD, PhD; Matcheri Keshavan, MD; Kevin Hill, MD

4:45-5:00 PM

Wrap-Up, Last Questions